AKT inhibitor VIII, Purity ≥98%

Cat. No.: X24-05-ZQ184

AKT inhibitor VIII, Purity ≥98%

Synonym: 612847-09-3; AKTI-1/2; Akt inhibitor

  • CAS Number: 612847-09-3
  • Compound CID: 135398501
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
AKT inhibitor VIII, soluble in DMSO and insoluble in ethanol and water, inhibits the phosphorylation of Akt with anti-inflammatory properties. It targets Akt1, Akt2, and Akt3.
Molecular Weight
551.6
Molecular Formula
C34H29N7O
Targets
Akt1: 58 nM; Akt2: 210 nM; Akt3: 2119 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 19 mg/mL (34.44 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
AKT inhibitor VIII can be used to investigate the impact of Akt inhibition in cancer and other diseases.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.